Thursday – Clinical Track 2A Survey

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Gender, ethnic, and age considerations for the use of neuromodulators in facial aesthetics
Patricia Ogilvie, MD (Germany)
Ptosis: What can we do about this?
Michael Kane, MD (USA)
Hyperhidrosis update
Marcus Naumann, MD (Germany)
Panel Discussion
YesNo
Gender, ethnic, and age considerations for the use of neuromodulators in facial aesthetics
Patricia Ogilvie, MD (Germany)
Ptosis: What can we do about this?
Michael Kane, MD (USA)
Hyperhidrosis update
Marcus Naumann, MD (Germany)
Panel Discussion
YesNo
Gender, ethnic, and age considerations for the use of neuromodulators in facial aesthetics
Patricia Ogilvie, MD (Germany)
Ptosis: What can we do about this?
Michael Kane, MD (USA)
Hyperhidrosis update
Marcus Naumann, MD (Germany)
Panel Discussion
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care